PT Siloam International Hospitals Tbk (FRA:2LS) Revenue: €676.9 Mil (TTM As of Mar. 2026)


FRA:2LS PT Siloam International Hospitals Tbk FRA:2LS
68 GF Score
Price €0.10
GF Value €0.13
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Siloam International Hospitals Tbk Revenue?

PT Siloam International Hospitals Tbk FRA:2LS -0.98% 68 Revenue is €676.9 Mil as of Mar. 2026. GuruFocus rates FRA:2LS with a GF Score™ of 68/100 and a GF Value™ of €0.13 (Modestly Undervalued). The stock has 2 warning signs investors should review.

PT Siloam International Hospitals Tbk's revenue for the three months ended in Mar. 2026 was €167.5 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was €676.9 Mil. PT Siloam International Hospitals Tbk's Revenue per Share for the three months ended in Mar. 2026 was €0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.05.

Good Sign:

PT Siloam International Hospitals Tbk has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of PT Siloam International Hospitals Tbk was 7.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 0.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, PT Siloam International Hospitals Tbk's highest 3-Year average Revenue per Share Growth Rate was 31.90% per year. The lowest was -0.40% per year. And the median was 11.10% per year.


PT Siloam International Hospitals Tbk  (FRA:2LS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


PT Siloam International Hospitals Tbk Revenue Related Terms


PT Siloam International Hospitals Tbk Revenue Historical Data

* Premium members only.

The historical data trend for PT Siloam International Hospitals Tbk's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Siloam International Hospitals Tbk Revenue Chart

PT Siloam International Hospitals Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 579.46 575.41 661.40 727.01 656.71

PT Siloam International Hospitals Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 170.58 163.10 171.38 174.91 167.48

FRA:2LS vs HCA, THC, DVA: Revenue Comparison

For the Medical Care Facilities subindustry, PT Siloam International Hospitals Tbk's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Siloam International Hospitals Tbk Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Siloam International Hospitals Tbk's Revenue distribution charts can be found below:

* The bar in red indicates where PT Siloam International Hospitals Tbk's Revenue falls into.


FRA:2LS
68GF Score
PT Siloam International Hospitals Tbk FRA:2LS
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Siloam International Hospitals Tbk Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €676.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of €676.9 Mil mean?
PT Siloam International Hospitals Tbk (FRA:2LS) has a Revenue of €676.9 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on PT Siloam International Hospitals Tbk and its competitors.
Is PT Siloam International Hospitals Tbk's Revenue too high?
PT Siloam International Hospitals Tbk's current Revenue is €676.9 Mil. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's Revenue compare to HCA and THC?
PT Siloam International Hospitals Tbk's Revenue of €676.9 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on PT Siloam International Hospitals Tbk and its competitors. PT Siloam International Hospitals Tbk's current Revenue is €676.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk (FRA:2LS) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.13, compared to a current price of €0.10 — trading 22.3% below its estimated fair value. The current Revenue is €676.9 Mil. PT Siloam International Hospitals Tbk's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current Revenue is €676.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued. The current stock price of €0.10 is trading 22.3% below its estimated GF Value™ of €0.13. GuruFocus considers PT Siloam International Hospitals Tbk to be Modestly Undervalued.

Key valuation signals for FRA:2LS:

  • Revenue: €676.9 Mil
  • GF Value™: €0.13 vs. price of €0.10 (22.3% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Siloam International Hospitals Tbk Business Description

Other Exchanges SILO:Indonesia
Address No. 15, Jalan Boulevard Sudirman, Floor 32, Gedung Fakultas Kedokteran Universitas Pelita Harapan, Lippo Village, Tangerang, IDN, 15810
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
68GF Score

Get the complete analysis for FRA:2LS

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.13
GF Value